Hyloris Announces Positive Clinical Study Results for Valacyclovir Oral Suspension (HY-029)

Source :: GlobeNewswire. December 26, 2023
Publication Year :: 2023
Abstract: Valacyclovir is an Antiviral Medication that is Commonly Used to Treat Infections Caused by Herpes Viruses Clinical Study Demonstrates Comparable Relative Bioavailability to Valaciclovir Tablets under fasted conditions NDA submission[sup.1] [...]

Subjects :: United States. Food and Drug Administration
Euronext Brussels S.A./N.V.
Patient compliance -- Research
Clinical trials -- Research
Valacyclovir -- Research
Securities industry -- Research
Oral medication -- Research
Securities industry
Banking, finance and accounting industries
Business

Tools